Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | TriMark Publications | Gene Expression Reagents Markets

Gene Expression Reagents Markets

The area of gene expression reagents is one of the newest and most important sectors of pharmaceutical and bioscience research and development. The term gene expression reagents refers to chemicals that are used in gene expression experiments that are performed to determine whether a particular gene is expressed--i.e., present--and in some cases at what levels, in a biological sample. The purpose of this TriMark Publications report is to describe the specific segments of the global gene expression reagents market. Within this area, the study covers those segments that are highly active in terms of innovation and growth. Specifically, this review examines the markets for gene expression reagents and small lab equipment all the way up to highly automated platforms. Emphasis is on those companies that are actively developing and marketing gene expression reagents for genomics research in the academic sector and the pharmaceutical, bioscience industry. This study concentrates on the laboratory reagent market segment and the companion gene expression reagents sector in the U.S. and around the world that use materials for genetic research. Particular attention is paid to those areas of the gene expression reagents sector that are showing the greatest growth or the most innovation. The report attempts to answer the following questions:

• What companies are the key players?

• What is the market for gene express reagents?

• What are the opportunities in gene expression reagents markets?

• What are the developing trends?

• Where are the new market growth areas?

• What are the most favored technology platforms?

• Where are the gene expression reagent technologies taking researchers?

• How are gene expression reagent technologies blending with more established laboratory procedures?

• What are the business trends in the industry?

The study surveys some of the leading companies known to be marketing, manufacturing or developing products for the gene expression reagents market for those sectors covered here. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market. The benefits of this report are:

• In-depth analysis of the major sectors of the gene expression reagent sectors, their size, growth rates and major drivers.

• Presentation of some of the emerging technology platforms, elucidating the potential areas that could gain traction in this market.

• Analysis of the partnerships and alliances the various key sector players have forged, as well as describing financings of these market participants, giving insight into potential market collaborations.

• Examination of new technology platforms that seek to dominate this new market, and to identify lead positions and potential future growth areas.

• An overview of the current state of gene expression assays used in drug development and the numerous opportunities that exist to increase the quality of genetic sequences evaluated.

• A profile of the gene expression customer and an analysis of factors influencing the adoption of specific gene exploration technology.

• A five-year projection of spending on new equipment and reagents.

• Impact of commercial gene reagents on genetic R&D.

Publication Date: 01-APR-07

Pages: 113

Format/Price: PDF document / $1,999.00
Table of Contents
Price: $1,999.00 / €1,337.33

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions